Growth Metrics

Fennec Pharmaceuticals (FENC) Operating Margin (2020 - 2025)

Fennec Pharmaceuticals posted quarterly Operating Margin of 16.06% for Q4 2025, up 2785.0% year-on-year from 0.56% in Q4 2024, and up 1159.14% on a QoQ basis from 1.52% in Q3 2025.

Fennec Pharmaceuticals (FENC) has 4 years of Operating Margin data on file, last reported at 16.06% in Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 2785.0% year-over-year to 16.06%; the trailing twelve-month figure through Dec 2025 stood at 3.4% (down 880.0% YoY), and the FY2025 full-year result was 3.39%, down 880.0% from the prior year.
  • Operating Margin for Q4 2025 stood at 16.06%, up from 1.52% in the prior quarter.
  • Across five years, Operating Margin topped out at 54.16% in Q1 2024 and bottomed at 314.25% in Q1 2023.
  • The 3-year median for Operating Margin is 17.14% (2023), against an average of 51.12%.
  • The widest annual swing landed in 2024, when Operating Margin jumped 36841 bps; it then slumped 6339 bps in 2025.
  • A 3-year view of Operating Margin shows it stood at 18.67% in 2023, then surged by 37 bps to 11.79% in 2024, then jumped by 236 bps to 16.06% in 2025.
  • The last three Operating Margin figures came in at 16.06% (Q4 2025), 1.52% (Q3 2025), and 28.31% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.02%
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn 16.06%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 16.06%
Sep 30, 2025 -1.52%
Jun 30, 2025 -28.31%
Mar 31, 2025 -9.23%
Dec 31, 2024 -11.79%
Sep 30, 2024 -74.59%
Jun 30, 2024 -69.39%
Mar 31, 2024 54.16%
Dec 31, 2023 -18.67%
Sep 30, 2023 -15.61%
Jun 30, 2023 -140.33%
Mar 31, 2023 -314.25%
Dec 31, 2020 -1,673.00%